Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Caenorhabditis elegans: nature and nurture gift to nematode parasitologists.

Salinas G, Risi G.

Parasitology. 2017 Dec 6:1-9. doi: 10.1017/S0031182017002165. [Epub ahead of print]

PMID:
29208057
2.

Molecular Weights of Bovine and Porcine Heparin Samples: Comparison of Chromatographic Methods and Results of a Collaborative Survey.

Bertini S, Risi G, Guerrini M, Carrick K, Szajek AY, Mulloy B.

Molecules. 2017 Jul 19;22(7). pii: E1214. doi: 10.3390/molecules22071214.

3.

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.

Wilcox MH, Gerding DN, Poxton IR, Kelly C, Nathan R, Birch T, Cornely OA, Rahav G, Bouza E, Lee C, Jenkin G, Jensen W, Kim YS, Yoshida J, Gabryelski L, Pedley A, Eves K, Tipping R, Guris D, Kartsonis N, Dorr MB; MODIFY I and MODIFY II Investigators.

N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615.

4.

Characterization of PF4-Heparin Complexes by Photon Correlation Spectroscopy and Zeta Potential.

Bertini S, Fareed J, Madaschi L, Risi G, Torri G, Naggi A.

Clin Appl Thromb Hemost. 2017 Oct;23(7):725-734. doi: 10.1177/1076029616685430. Epub 2017 Jan 25.

PMID:
28118750
5.

Carboxymethylinulin-Chitosan Nanoparticles for the Delivery of Antineoplastic Mitoxantrone.

Merli D, Pivi F, Profumo A, Quadrelli P, Milanese C, Risi G, Visai L.

ChemMedChem. 2016 Oct 5. doi: 10.1002/cmdc.201600385. [Epub ahead of print]

PMID:
27704697
6.

Study of QCL Laser Sources for the Realization of Advanced Sensors.

de Risi G, Columbo LL, Brambilla M.

Sensors (Basel). 2015 Aug 5;15(8):19140-56. doi: 10.3390/s150819140.

7.

Ebola and provision of critical care.

Murthy S; Ebola Clinical Care authors group.

Lancet. 2015 Apr 11;385(9976):1392-3. doi: 10.1016/S0140-6736(15)60712-7. No abstract available.

PMID:
25890414
8.

Being ready to treat Ebola virus disease patients.

Brett-Major DM, Jacob ST, Jacquerioz FA, Risi GF, Fischer WA 2nd, Kato Y, Houlihan CF, Crozier I, Bosa HK, Lawler JV, Adachi T, Hurley SK, Berry LE, Carlson JC, Button TC, McLellan SL, Shea BJ, Kuniyoshi GG, Ferri M, Murthy SG, Petrosillo N, Lamontagne F, Porembka DT, Schieffelin JS, Rubinson L, O'Dempsey T, Donovan SM, Bausch DG, Fowler RA, Fletcher TE.

Am J Trop Med Hyg. 2015 Feb;92(2):233-7. doi: 10.4269/ajtmh.14-0746. Epub 2014 Dec 15.

9.

Clinical illness and outcomes in patients with Ebola in Sierra Leone.

Schieffelin JS, Shaffer JG, Goba A, Gbakie M, Gire SK, Colubri A, Sealfon RS, Kanneh L, Moigboi A, Momoh M, Fullah M, Moses LM, Brown BL, Andersen KG, Winnicki S, Schaffner SF, Park DJ, Yozwiak NL, Jiang PP, Kargbo D, Jalloh S, Fonnie M, Sinnah V, French I, Kovoma A, Kamara FK, Tucker V, Konuwa E, Sellu J, Mustapha I, Foday M, Yillah M, Kanneh F, Saffa S, Massally JL, Boisen ML, Branco LM, Vandi MA, Grant DS, Happi C, Gevao SM, Fletcher TE, Fowler RA, Bausch DG, Sabeti PC, Khan SH, Garry RF; KGH Lassa Fever Program; Viral Hemorrhagic Fever Consortium; WHO Clinical Response Team.

N Engl J Med. 2014 Nov 27;371(22):2092-100. doi: 10.1056/NEJMoa1411680. Epub 2014 Oct 29.

11.

Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults ≥ 50 years of age.

Dayan GH, Bevilacqua J, Coleman D, Buldo A, Risi G.

Vaccine. 2012 Oct 19;30(47):6656-64. doi: 10.1016/j.vaccine.2012.08.063. Epub 2012 Sep 7.

PMID:
22959989
12.

Safety and long-term humoral immune response in adults after vaccination with an H1N1 2009 pandemic influenza vaccine with or without AS03 adjuvant.

Ferguson M, Risi G, Davis M, Sheldon E, Baron M, Li P, Madariaga M, Fries L, Godeaux O, Vaughn D.

J Infect Dis. 2012 Mar 1;205(5):733-44. doi: 10.1093/infdis/jir641.

PMID:
22315336
13.

A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy.

Clifford DB, Simpson DM, Brown S, Moyle G, Brew BJ, Conway B, Tobias JK, Vanhove GF; NGX-4010 C119 Study Group.

J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):126-33. doi: 10.1097/QAI.0b013e31823e31f7.

PMID:
22067661
14.

Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study.

Langley JM, Risi G, Caldwell M, Gilderman L, Berwald B, Fogarty C, Poling T, Riff D, Baron M, Frenette L, Sheldon E, Collins H, Shepard M, Dionne M, Brune D, Ferguson L, Vaughn D, Li P, Fries L.

J Infect Dis. 2011 Jun 15;203(12):1729-38. doi: 10.1093/infdis/jir172.

15.
16.

Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults.

Langley JM, Frenette L, Ferguson L, Riff D, Sheldon E, Risi G, Johnson C, Li P, Kenney R, Innis B, Fries L.

J Infect Dis. 2010 Jun 1;201(11):1644-53. doi: 10.1086/652701.

PMID:
20423222
17.

Preparing a community hospital to manage work-related exposures to infectious agents in BioSafety level 3 and 4 laboratories.

Risi GF, Bloom ME, Hoe NP, Arminio T, Carlson P, Powers T, Feldmann H, Wilson D.

Emerg Infect Dis. 2010 Mar;16(3):373-8. doi: 10.3201/eid1603.091485.

18.

[Medical assessments of the years 2004 and 2005 at the Diagnostic Medical Department MEDAS, University Clinic Basel - a critical analysis].

Fouradoulas M, Risi G, Gyr N.

Praxis (Bern 1994). 2010 Feb 17;99(4):229-33. doi: 10.1024/1661-8157/a000033. German.

PMID:
20166048
19.

In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections.

Hamilton SM, Bryant AE, Carroll KC, Lockary V, Ma Y, McIndoo E, Miller LG, Perdreau-Remington F, Pullman J, Risi GF, Salmi DB, Stevens DL.

Clin Infect Dis. 2007 Dec 15;45(12):1550-8. doi: 10.1086/523581.

PMID:
18190315
20.

[Low back pain--from work incapacity to disability].

Risi G.

Ther Umsch. 2007 Aug;64(8):409-13. German.

PMID:
17987993

Supplemental Content

Loading ...
Support Center